US Patent Issued to MINT BIOTECHNOLOGIES on Oct. 6 for "Genetically engineered microorganism with high yield of L-isoleucine and method for producing L-isoleucine by fermentation" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,424, issued on Oct. 6, was assigned to MINT BIOTECHNOLOGIES Co. LTD. (Hangzhou, China).

"Genetically engineered microorganism with high yield of L-isoleucine and method for producing L-isoleucine by fermentation" was invented by Kechun Zhang (Hangzhou, China), Jingyu Wang (Hangzhou, China) and Jilong Wang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for producing L-isoleucine at a higher yield by fermentation includes the step of using a genetic engineering method to obtain a genetically engineered strain. The genetically engineered strain has a threonine deaminase gene substantially releasing the inhibition of L-isoleucin...